Sharp inequalities for sine and cosine on complex circles and applications
International Journal of Open Problems in Computer Science and Mathematics · 2026
DOI: 10.15849/ijopcm.v19i3.68 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Open Problems in Computer Science and Mathematics, 2026. Verfasst von Mohamed Bouali.
Abstract (Originalsprache)
We investigate sharp inequalities for the functions | sin z| and | cos z| along circles in the complex plane. Building on recent results of Qi, we establish precise bounds for the quantities | sin(reiθ)| − | cos(reiθ)| and | sin(reiθ) − cos(reiθ)|.We show that their behavior undergoes a phase transition governed by a unique critical parameter r0 defined by cos(2r0) =2r0. As an application, we completely resolve several open problems posed by Bagul and Chesneau concerning doublesided inequalities for trigonometric and hyperbolic functions.In particular, we prove thatsin(kx)/kx+ ksin x/x> 1 + k cos x, holds if and only if k ∈ (0, 2), and that sinh(qx)/qx+ qsinh x/x> 1 + q cosh xholds if and only if q ≥ 2. We further obtain weighted extensions of these inequalities. Our approach combines complexanalytic techniques with sharp real-variable inequalities and reveals new connections between classical inequalities and the geometry of analytic functions on circles.
Zitieren
APA
Bouali, M. (2026). Sharp inequalities for sine and cosine on complex circles and applications. International Journal of Open Problems in Computer Science and Mathematics. https://doi.org/10.15849/ijopcm.v19i3.68
Vancouver
Bouali M. Sharp inequalities for sine and cosine on complex circles and applications. International Journal of Open Problems in Computer Science and Mathematics. 2026. doi:10.15849/ijopcm.v19i3.68
BibTeX
@article{Bouali2026,
author = {Bouali, Mohamed},
title = {Sharp inequalities for sine and cosine on complex circles and applications},
journal = {International Journal of Open Problems in Computer Science and Mathematics},
year = {2026},
doi = {10.15849/ijopcm.v19i3.68}
}
EUVIMED